- cafead Jun 15, 2022 at 07:52: PM
via A new approach to financing could become available to pre-revenue biotech companies if Congress signs off on it.
The San Francisco Business Times reported that industry lobbyists are urging Congress to approve a plan that will allow companies that are not yet generating revenue from the sales of their assets to be allowed to sell net operating loss carryforwards to larger companies. In other words, the biotech companies are looking to sell their losses to larger companies to provide them with a tax credit that would allow them to lower their tax burden.
article source
The San Francisco Business Times reported that industry lobbyists are urging Congress to approve a plan that will allow companies that are not yet generating revenue from the sales of their assets to be allowed to sell net operating loss carryforwards to larger companies. In other words, the biotech companies are looking to sell their losses to larger companies to provide them with a tax credit that would allow them to lower their tax burden.
article source